News Desk: Bayer, FTC Trial Addresses Claims Substantiation

Monday marked the beginning of a bench trial that will shine light on whether claims made by Bayer Corporation about the benefits of a probiotic supplement lacked adequate substantiation. The issue of substantiation has been front-and-center in the industry, and has left supplement companies figuring out how to balance science and marketing—no easy feat.

Monday marked the beginning of a bench trial that will shine light on whether claims made by Bayer Corporation about the benefits of a probiotic supplement lacked adequate substantiation.

The issue of substantiation has been front-and-center in the industry, as FTC continues to push for a precedent that would require claims touting supplement benefits are substantiated by human clinical trials. This emphasis on claims substantiation has left supplement companies figuring out how to balance science and marketing—no easy feat.

There are many ways to prevent regulatory trouble when marketing clinical research. One way is to involve the marketing team in the design of the research study. Regulatory and legal experts can also help with study design in order to maintain compliance. To learn more about how to properly market research and ensure claims are adequately supported, download INSIDER’s free “Let’s Get Clinical” digital issue by visiting naturalproductsinsider.com.

For a closer look at the Bayer trial, visit the blog, “Bayer Braces for Trial in Probiotic Supplement Dispute with FTC,” by Josh Long.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish